Biopharma Business

Tag "Darzalex"

EU expands use of Janssen’s Darzalex

EU regulators have expanded the scope of Janssen’s Darzalex to include patients with multiple myeloma who have received at least one prior therapy, when given in combination with lenalidomide and

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here